These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18973819)

  • 1. Is urethane-chloralose anaesthesia appropriate for pharmacokinetic-pharmacodynamic assessment? Studies with carvedilol.
    Bertera FM; Di Verniero CA; Mayer MA; Bramuglia GF; Taira CA; Höcht C
    J Pharmacol Toxicol Methods; 2009; 59(1):13-20. PubMed ID: 18973819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantioselective pharmacokinetic-pharmacodynamic modelling of carvedilol in a N-nitro-l-arginine methyl ester rat model of secondary hypertension.
    Di Verniero CA; Bertera F; Buontempo F; Bernabeu E; Chiappetta D; Mayer MA; Bramuglia GF; Taira CA; Höcht C
    J Pharm Pharmacol; 2010 Jul; 62(7):890-900. PubMed ID: 20636877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic properties of carvedilol in fructose hypertensive rats.
    Bertera F; Di Verniero CA; Mayer MA; Chiappetta D; Buontempo F; Polizio AH; Taira CA; Höcht C
    Xenobiotica; 2012 Feb; 42(2):206-19. PubMed ID: 21892881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats.
    Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
    Hypertens Res; 2014 Mar; 37(3):194-201. PubMed ID: 24132009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic-pharmacodynamic modeling of diltiazem in spontaneously hypertensive rats: a microdialysis study.
    Bertera FM; Mayer MA; Opezzo JA; Taira CA; Bramuglia GF; Höcht C
    J Pharmacol Toxicol Methods; 2007; 56(3):290-9. PubMed ID: 17560132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different pharmacodynamic models for pharmacokinetic-pharmacodynamic (PK-PD) modeling of carvedilol.
    Liu XY; Wang BJ; Yuan GY; Guo RC
    Yao Xue Xue Bao; 2009 Apr; 44(4):406-11. PubMed ID: 19545060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs.
    Arsenault WG; Boothe DM; Gordon SG; Miller MW; Chalkley JR; Petrikovics I
    Am J Vet Res; 2005 Dec; 66(12):2172-6. PubMed ID: 16379664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a pharmacokinetic/pharmacodynamic model for carvedilol to predict beta1-blockade in patients with congestive heart failure.
    Tenero DM; Henderson LS; Campanile AM; Baidoo CA; Boyle D
    Am J Cardiol; 2006 Oct; 98(7A):27L-31L. PubMed ID: 17023229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic/pharmacodynamic modeling of the cardiovascular effects of beta blockers in humans.
    Baek IH; Yun MH; Yun HY; Kwon KI
    Arch Pharm Res; 2008 Jun; 31(6):814-21. PubMed ID: 18563366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different pharmacodynamic models for PK-PD modeling of verapamil in renovascular hypertension.
    Bertera FM; Mayer MA; Opezzo JA; Taira CA; Höcht C
    J Pharmacol Toxicol Methods; 2008; 57(3):212-9. PubMed ID: 18442930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study.
    Höcht C; Di Verniero C; Opezzo JA; Bramuglia GF; Taira CA
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):310-8. PubMed ID: 16733693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of a new controlled-release formulation of carvedilol.
    Tenero DM; Henderson LS; Baidoo CA; Harter AH; Campanile AM; Danoff TM; Boyle D
    Am J Cardiol; 2006 Oct; 98(7A):5L-16L. PubMed ID: 17023227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of microdialysis as a technique for pharmacokinetic-pharmacodynamic (PK-PD) modeling of antihypertensive beta-blockers.
    Höcht C; DiVerniero C; Opezzo JA; Taira CA
    J Pharmacol Toxicol Methods; 2005; 52(2):244-50. PubMed ID: 16125622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the effects of nitric oxide synthase and cyclo-oxygenase inhibition on duodenal functions in rats anaesthetized with inactin, urethane or alpha-chloralose.
    Sababi M; Nylander O
    Acta Physiol Scand; 1996 Sep; 158(1):45-52. PubMed ID: 8876747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute cardiovascular effects and pharmacokinetics of carvedilol in healthy dogs.
    Sawangkoon S; Miyamoto M; Nakayama T; Hamlin RL
    Am J Vet Res; 2000 Jan; 61(1):57-60. PubMed ID: 10630779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cilostazol on the pharmacokinetics of carvedilol after oral and intravenous administration in rats.
    Lim TH; Cho YA; Choi DH
    J Physiol Pharmacol; 2015 Aug; 66(4):591-7. PubMed ID: 26348083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study.
    Rathod R; Prasad LP; Rani S; Nivsarkar M; Padh H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 857(2):219-23. PubMed ID: 17702675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats.
    Kim MS; Baek IH
    Eur J Pharm Sci; 2018 Jan; 111():13-19. PubMed ID: 28942006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.